News & Analysis as of

Domestic Dealmaking Capital Markets

White & Case LLP

“Magnificent Seven” ride again as AI spurs rise in US tech M&A

White & Case LLP on

Dealmaking makes a comeback as tech giants battle for dominance in artificial intelligence - Dealmakers in the technology sector have battled headwinds over the past few years. Global deal value sank to US$456.6 billion in...more

Latham & Watkins LLP

Public M&A Day in Frankfurt

Latham & Watkins LLP on

Latham hosted our second Public M&A Day in Frankfurt, bringing together senior executives and Latham partners to discuss opportunities in the current public M&A sector. Renowned experts and prominent keynote speakers...more

McDermott Will & Emery

Credit Conditions | March 2024

McDermott Will & Emery on

Higher interest rates presented a challenging environment for dealmakers and the debt markets in 2023. But what does 2024 have in store? In this edition of Credit Conditions, we look back at last year’s key market trends and...more

White & Case LLP

Dealmakers turn to M&A to combat supply disruption

White & Case LLP on

Robust supply chains are vital to our closely connected global economy. Yet escalating geopolitical tensions, persistent inflation and a fragile macroeconomic outlook are presenting businesses with a fresh wave of supply...more

White & Case LLP

Whole-business securitization on the M&A radar

White & Case LLP on

Whole-business securitization (WBS), a structured finance product where a company issues secured debt against substantially all of its cash-yielding assets, is now on the radar of dealmakers seeking ways to manage M&A...more

Bass, Berry & Sims PLC

Healthcare Trends & Transactions Q2 2023

Bass, Berry & Sims PLC on

The healthcare M&A market appears to be steadying. Although deal activity through the year appears slightly below the high-water marks for the corresponding period of 2022, deal activity is generally up from the first quarter...more

McDermott Will & Emery

Top Takeaways | Specialty Spotlight: Gastroenterology

McDermott Will & Emery on

In this moderated session featuring perspectives from top gastroenterology (GI) executives, panelists explored the thriving state of marketing and dealmaking in this field. ...more

White & Case LLP

Technology leads the charge yet again

White & Case LLP on

Technology continued to drive M&A activity in 2022 despite the odds being stacked against the sector - Although the record-breaking deal activity of 2021 spilled over into 2022, headwinds in the first quarter developed...more

White & Case LLP

Mixed Signals: US M&A FY 2022

White & Case LLP on

Although the record-breaking deal activity of 2021 spilled over into 2022, headwinds in the first quarter developed into a significant slowdown during the rest of 2022, with an expectation of continued slowness as we enter...more

White & Case LLP

US M&A in review: Momentum can only take you so far

White & Case LLP on

M&A started strong in 2022 with robust deal activity and megadeals dominating the landscape that was largely the result of unprecedented spillover from 2021. But then, things took a turn and deals stalled in the second half...more

Skadden, Arps, Slate, Meagher & Flom LLP

US M&A Levels Remain Healthy, but Due Diligence and Deal Protections Will Become Even More Critical

Acquisition market participants in the U.S. approached dealmaking with greater caution in 2022 than they did in 2021. Steadily rising interest rates and financing costs, persistent inflation, geopolitical uncertainty,...more

White & Case LLP

What’s next for US M&A?

White & Case LLP on

As predicted in our previous M&A report, 2022 has not lived up to the runaway performance of 2021. As activity—still at impressive levels considering everything that has been thrown at the deal market—takes a breather, we...more

White & Case LLP

US M&A settles back down

White & Case LLP on

Explore the data The headline for the first half of 2022 is that US M&A markets are still remarkably healthy, despite a confluence of headwinds. Without question, 2021 was an exceptional year, fueled by pent-up demand,...more

McDermott Will & Emery

HPE Miami 2022 Financing Healthcare Deals: Strategies for the Year Ahead

In this session, Stephanie McCann, Partner and Co-Head of McDermott’s Finance Practice, led a wide-ranging discussion of critical strategies for investors to consider as they seek sources of capital to finance healthcare...more

White & Case LLP

Buoyant capital markets help fuel dealmaking

White & Case LLP on

Most of 2021 was characterized by free-flowing capital, as government aid propped up economies in response to COVID-19. Low interest rates and other central bank stimulus measures contributed to an environment that helped see...more

White & Case LLP

Sector overview: Strong M&A activity pervades nearly every sector

White & Case LLP on

Dealmakers in almost every industry had an outstandingly busy 2021. With just a few exceptions, the M&A boom swept across the US economy with deal values, in particular, up significantly on 2020 totals. Nevertheless,...more

McDermott Will & Emery

2022 J.P. Morgan Healthcare Conference: Life Sciences Investment Forum

Despite offering one of the lowest total deal values on record, 2021 was an active M&A year. Due to the strong capital markets, a seller’s market continued, creating additional urgency for biopharma companies to accelerate...more

White & Case LLP

Canadian outbound dealmaking rebounds

White & Case LLP on

Canadian dealmakers are betting on large overseas purchases as market confidence returns - Canadian dealmakers have become a major presence beyond their borders, conducting a total of 361 outbound deals worth a total of...more

White & Case LLP

Vietnam M&A heads for another record in 2021

White & Case LLP on

High-growth industries continue to attract investor interest despite COVID disruptions - Vietnam’s M&A activity is set for another robust year following 2020’s potent performance. In the first three quarters, deals with...more

19 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide